Get the Stockscreener App
1.755
11.87%
0.155
Precigen Inc stock is traded at $1.755, with a volume of 3.36M.
It is up +11.87% in the last 24 hours and up +35.61% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$1.60
Open:
$1.62
24h Volume:
3.36M
Relative Volume:
2.14
Market Cap:
$468.59M
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-4.50
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
+32.59%
1M Performance:
+35.61%
6M Performance:
+51.69%
1Y Performance:
+29.71%
1-Day Range:
$1.53
$1.83
1-Week Range:
$1.25
$1.83
52-Week Range:
$0.6513
$1.93
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.7514 | 468.59M | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.06 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.44 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
652.71 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.65 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.25 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
PGEN Shares Experience Surge in Value - Knox Daily
Precigen Inc (NASDAQ: PGEN): Can A Stock Be Up 42.86% YTD, And Still Be A Loser - Marketing Sentinel
A Deep Dive into Precigen Inc (PGEN) Stock Performance - The InvestChronicle
JP Morgan analysts downgrades an Underweight rating for Precigen Inc (PGEN) - Knox Daily
Is Precigen Inc (PGEN) a good investment opportunity? - US Post News
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World
HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World
Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World
Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat
LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat
Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World
Precigen shares rebound above Nasdaq minimum bid price - MSN
Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia
Should You Invest in Precigen (PGEN)? - MSN
Jane Street Group LLC Reduces Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment By Investing.com - Investing.com Australia
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment - Investing.com India
Precigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat
Precigen to Present Plans for Realizing Commercial Vision for PR - GuruFocus.com
Precigen Files BLA for Breakthrough RRP Treatment PRGN-2012, Targets 27,000 US Patients - StockTitan
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com
Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Barclays PLC Acquires 124,141 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital Management LLC - Defense World
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - MSN
Investors Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - Defense World
Traders Purchase High Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Exploring 3 Prominent High Growth Tech Stocks In The United States - Simply Wall St
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally - MSN
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by State Street Corp - Defense World
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precigen Inc Stock (PGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| KIRK RANDAL J | Director |
Aug 09 '24 |
Buy |
0.85 |
23,529,411 |
19,999,999 |
64,547,214 |
| KIRK RANDAL J | Director |
Mar 09 '24 |
Option Exercise |
0.00 |
213,675 |
0 |
32,051,461 |
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):